Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01317849

China Stroke Secondary Prevention Trial

Folic Acid and B Vitamins for Secondary Prevention of Stroke : A Double-blinded Randomized Controlled Trial

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The CSSPT study is a multi-center, randomized, double blinded, placebo-controlled secondary stroke prevention trial in China to determine whether the addition of folic acid and vitamin supplements will reduce recurrent stroke events and other combined incidence of recurrent vascular events and vascular death.

Detailed description

The CSSPT study is a multi-center, randomized, double blinded, placebo-controlled secondary stroke prevention trial in China to determine whether the addition of folic acid and vitamin supplements will reduce recurrent stroke events and other combined incidence of recurrent vascular events and vascular death in patients with recent stroke or transient ischemic attack (TIA). All patients presenting to one of the participating neurologists or general physicians within one months of stroke (ischemic or hemorrhagic) or TIA (eye or brain) are eligible for this trial. Eligible patients will be randomized in a double-blinded fashion to receive multi-vitamins or placebo. The primary outcome event is the composite event "stroke, myocardial infarction, or death from any vascular cause", whichever occurs first. Our target is to recruit a total of 8,000 patients over the two years with a median follow-up of 3 years. Recruitment to the trial began in July 2011 and is planned to continue until December 2013. The investigators aim to complete final follow-up by the end of 2016.

Conditions

Interventions

TypeNameDescription
DRUGFolic Acid0.8mg
DRUGVitamin B610mg
DRUGVitamin B12500ug
DRUGplacebo0.8 mg
DRUGplacebo10mg
DRUGplacebo500ug

Timeline

Start date
2011-07-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2011-03-17
Last updated
2014-08-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01317849. Inclusion in this directory is not an endorsement.